DBV Technologies SA (DBVT)
18.56
-0.18
(-0.99%)
USD |
NASDAQ |
May 19, 15:28
DBV Technologies Research and Development Expense (Quarterly) : 31.31M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cellectis SA | 23.09M |
| Akari Therapeutics Plc | 1.084M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 4.329M |
| Mereo BioPharma Group Plc | 4.739M |